Clinical Trial Update: Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ticagrelor and clopidogrel using optical coherence tomography has completed and evaluated outcomes in thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Thrombosis | Phase 4 | Status: COMPLETED